Published August 26, 2008 | Version Accepted Version
Journal Article Open

Demonstration of functional α4-containing nicotinic receptors in the medial habenula

  • 1. ROR icon California Institute of Technology
  • 2. ROR icon University of Victoria
  • 3. ROR icon Baylor College of Medicine
  • 4. ROR icon University of Alabama at Birmingham

Abstract

The medial habenula (MHb) exhibits exceptionally high levels of nicotinic acetylcholine receptors (nAChRs), but it remains unclear whether all expressed nAChR subunit mRNAs are translated to form functional receptors. In particular α4 subunits have not been reported to have any functional role, despite strong α4 mRNA expression in the ventrolateral MHb. We studied a strain of knock-in mice expressing fluorescent α4* nAChRs (α4YFP), as well as a knock-in strain expressing hypersensitive α4* nAChRs (α4L9'A). In α4YFP mice, there was strong fluorescence in the ventrolateral MHb. In hypersensitive α4L9'A mice, injections of a low dose of nicotine (0.1 mg/kg) led to strong c-fos expression in only the ventrolateral region of the MHb, but not in the MHb of wild-type (WT) mice. In MHb slice recordings, ventrolateral neurons from α4L9'A mice, but not from WT mice, responded robustly to nicotine (1 μM). Neurons in the medial aspect of the MHb had >10-fold smaller responses. Thus α4* nAChRs contribute to the selective activation of a subset of MHb neurons. Subunit composition analysis based on gain-offunction knock-in mice provides a useful experimental paradigm.

Additional Information

© 2008 Elsevier Ltd. Received 6 August 2008; accepted 8 August 2008; available online 26 August 2008. This work was supported by PHS grants NS31669, DA17173, DA17279, California Tobacco-Related Disease Research Project, and the Philip Morris External Research Fund. R.N. was supported by a NARSAD Young Investigator Award.

Attached Files

Accepted Version - nihms87064.pdf

Files

nihms87064.pdf

Files (951.0 kB)

Name Size
md5:5d59af1186e683ff09a3a494c714e4e3
951.0 kB Preview Download

Additional details

Identifiers

PMCID
PMC2645341
Eprint ID
13433
DOI
10.1016/j.neuropharm.2008.08.021
Resolver ID
CaltechAUTHORS:FONnp09

Related works

Funding

PHS
NS31669
PHS
DA17173
PHS
DA17279
California Tobacco-Related Disease Research Program
Philip Morris External Research Fund
NARSAD Young Investigator Award

Dates

Created
2009-04-22
Created from EPrint's datestamp field
Updated
2021-11-08
Created from EPrint's last_modified field